文献速递神经肿瘤

56例颅内淋巴浆细胞丰富型脑膜瘤的临床、影像与病理特征

Clinical, Radiologic, and Pathologic Features of 56 Cases of Intracranial Lymphoplasmacyte-Rich Meningioma.
PubMed 文献 · World Neurosurg · 2017-07-01

基于北京天坛医院2009年6月至2016年11月约10,908例颅内脑膜瘤手术病例,识别出56例经病理证实的淋巴浆细胞丰富型脑膜瘤(LPRM),占约0.51%。患者平均年龄44.6岁,男女各28例。中位随访41.5个月,5例复发,3年和5年无进展生存率分别为94.6%和92.9%。颅底位置与长期预后不良独立相关,肿瘤大小≥45 mm、边界不清和颅底位置显著限制切除程度。作者认为,引起严重神经功能缺损的根治性切除是不必要的。

要点

  • LPRM约占颅内脑膜瘤0.51%(56/10,908),无显著性别差异(男28例、女28例)。
  • 中位随访41.5个月,5例复发,3年和5年无进展生存率分别为94.6%和92.9%。
  • 颅底位置与长期预后不良独立相关;肿瘤大小≥45 mm、边界不清和颅底位置限制切除程度。

核心结论

  • 颅内LPRM是罕见的脑膜瘤亚型,无性别差异且复发率低,长期生存可期。
  • 颅底位置和骨破坏是长期预后不良的独立危险因素。
  • 作者认为,引起严重神经功能缺损的根治性肿瘤切除是不必要的。

研究设计与样本

  • 回顾性分析北京天坛医院2009年6月至2016年11月约10,908例手术切除的颅内脑膜瘤,识别所有经病理证实的LPRM病例。
  • 共56例LPRM,占颅内脑膜瘤约0.51%(56/10,908)。
  • 采用统计学分析确定与预后和肿瘤切除相关的参数。

主要发现

  • 患者平均年龄44.6岁,男28例、女28例,无显著性别偏好。
  • 全切除45例,次全切除9例,部分切除2例。
  • 出院时Karnofsky功能状态评分和神经功能改善42例(75.0%),恶化14例(25.0%)。
  • 中位随访41.5个月(范围5-97个月),5例复发,3年和5年无进展生存率分别为94.6%和92.9%,1例死于肿瘤复发。
  • 末次随访时Karnofsky功能状态评分改善48例(85.7%),恶化7例(12.5%),死亡1例(1.8%)。

关键数值与推荐

  • 单因素分析显示,肿瘤切除程度和颅底位置与短期预后显著相关。
  • 颅底位置与长期预后不良风险增加显著相关。
  • 肿瘤大小≥45 mm、肿瘤边界不清和颅底位置显著限制肿瘤切除程度。

临床怎么用

  • 作者认为,引起严重神经功能缺损的根治性肿瘤切除是不必要的。
  • 颅底LPRM因边界不清和包绕重要神经血管结构,显微手术治疗仍具挑战性。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE: Intracranial lymphoplasmacyte-rich meningioma (LPRM) is rarely reported because of its extremely low incidence, and current understanding of this disease is poor. We analyzed the incidence and clinical, radiologic, pathologic, and prognostic features of intracranial LPRMs. METHODS: Approximately 10,908 intracranial meningiomas were surgically resected in Beijing Tiantan Hospital between June 2009 and November 2016. All pathologically proven LPRM cases were identified. Statistical analysis was performed to determine which parameters were associated with prognoses and tumor resection. RESULTS: LPRMs accounted for approximately 0.51% of intracranial meningiomas (56 of 10,908). Patients with LPRM had a mean age of 44.6 years and there was no significant gender preference (28 male and 28 female). Gross total resection was achieved in 45 cases, subtotal resection in 9 cases, and partial resection in 2 cases. At discharge, Karnofsky Performance Scale scores and neurologic function improved in 42 cases (75.0%) and worsened in 14 cases (25.0%). At the 41.5 months median follow-up (range, 5-97 months), 5 patients had tumor recurrence, and the 3-year and 5-year progression-free survival rates were 94.6% and 92.9%, respectively. One patient died of tumor recurrence. At the latest follow-up, Karnofsky Performance Scale scores improved in 48 cases (85.7%), worsened in 7 cases (12.5%), and 1 patient died (1.8%). Univariate analysis showed that the extent of tumor resection and tumors located in the skull base were significantly associated with short-term outcomes. Skull base location was significantly associated with increased risk of worse long-term outcomes. Tumor size ≥45 mm, poorly defined tumor border, and skull base location significantly limited the extent of tumor resection. CONCLUSIONS: Intracranial LPRM is a rare subtype of meningioma with no gender difference and low recurrence. Long-term survival is expected, although tumors located in the skull base and bone destruction are independent risk factors of poor long-term outcomes. Microsurgical treatment of skull base LPRM remains a formidable challenge because of poorly defined borders and critical neurovascular structure encasement. Radical tumor resection, which induces severe neurologic deficits, is unnecessary.

来源:World Neurosurg,查看原文。版权归原作者所有。

引用

  1. Tao X, Wang K, Dong J, et al. Clinical, Radiologic, and Pathologic Features of 56 Cases of Intracranial Lymphoplasmacyte-Rich Meningioma. World Neurosurg. 2017. PMID: 28673887. doi:10.1016/j.wneu.2017.06.143

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。